National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 16683 [2019-07966]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 77 / Monday, April 22, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the duration of the meeting of the
Clinical Trials Review Committee, June
20, 2019, 8:00 a.m. to June 21, 2019,
5:00 p.m., Hilton Garden Inn Bethesda,
7301 Waverly Street, Bethesda, MD
20814 which was published in the
Federal Register on February 15, 2019,
84 FR 4490.
The Clinical Trials Review Committee
will be reduced to a one-day meeting on
June 20, 2019 in the same location. The
meeting is closed to the public.
Dated: April 16, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07966 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
amozie on DSK9F9SC42PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; HEAL Initiative:
Pragmatic and Implementation Studies for
the Management of Pain to Reduce Opioid
Prescribing.
Date: May 29–30, 2019.
Time: 5:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Blvd., Gaithersburg, MD 20878.
Contact Person: Jessica Marie McKlveen,
Ph.D., Scientific Review Officer, Office of
Scientific Review, Division of Extramural
VerDate Sep<11>2014
17:22 Apr 19, 2019
Jkt 247001
Activities NCCIH, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda, MD 20892,
jessica.mcklveen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: April 15, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07962 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
16683
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 16, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07956 Filed 4–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Asthma
Education Prevention Program
Coordinating Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Asthma
Education Prevention Program Coordinating
Committee.
Date: June 24, 2019.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: Welcome, guidelines update and
implementation, and future directions/role of
NAEPPCC.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Susan Shero, BSN, MS,
Program Officer, CTRIS, Center for
Translational Research & Implementation
Science, National Heart, Lung and Blood
Institute National Institutes of Health, 6075
Rockledge Drive, Suite 6197, Bethesda, MD
20892, 301–496–1051, susan.shero@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/health-pro/resources/
lung/naci/asthma-info/naepp.htm, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Linking Provider Recommendation to
Adolescent HPV Uptake.
Date: May 16, 2019.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Tasmeen Weik, DRPH,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141,
Bethesda, MD 20892, 301–827–6480, weikts@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA
Review: Bioengineering Sciences and
Technologies (R15).
Date: May 30, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: David Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, 301–435–
2902, filpuladr@mail.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Nanotechnology Study Section.
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 84, Number 77 (Monday, April 22, 2019)]
[Notices]
[Page 16683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07966]
[[Page 16683]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Amended Notice of
Meeting
Notice is hereby given of a change in the duration of the meeting
of the Clinical Trials Review Committee, June 20, 2019, 8:00 a.m. to
June 21, 2019, 5:00 p.m., Hilton Garden Inn Bethesda, 7301 Waverly
Street, Bethesda, MD 20814 which was published in the Federal Register
on February 15, 2019, 84 FR 4490.
The Clinical Trials Review Committee will be reduced to a one-day
meeting on June 20, 2019 in the same location. The meeting is closed to
the public.
Dated: April 16, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-07966 Filed 4-19-19; 8:45 am]
BILLING CODE 4140-01-P
